Arcturus Therapeutics Holdings Inc
ARCT
Market Cap$875.82M
Close$
$-27.74
191.2% downside
Current Fair Value
191.2% downsideOvervalued by 191.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $875.82 Million |
|---|---|
| Enterprise Value | $609.72 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.12 |
| Beta | 1.62 |
| Outstanding Shares | 26,915,243 |
| Avg 30 Day Volume | 544,732 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -29.46 |
|---|---|
| PEG | 26.79 |
| Price to Sales | 5.07 |
| Price to Book Ratio | 3.04 |
| Enterprise Value to Revenue | 3.66 |
| Enterprise Value to EBIT | -7.8 |
| Enterprise Value to Net Income | -21 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.09 |
Revenue Sources
No data
ESG Score
No data